MedTrace Logo

Defining COVID-19 Infection Severity on Presentation to Hospital

NCT05677789 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2023-01-10

No results posted yet for this study

Summary

In the assessment of severity in coronavirus disease 2019 (COVID-19), the modified Brit\_x0002\_ish Thoracic Society (mBTS)，CURB65 et al. rules identifies patients with severe pneumonia but not patients who might be suitable for home management. A multicentre prospective study was conducted to derive and validate a practical severity assessment model for stratifying adults hospitalised with COVID-19 into different management groups.

Conditions

Interventions

DIAGNOSTIC_TEST

Medical observation

Likely suitable for home treatment

DIAGNOSTIC_TEST

Supportive treatment (BSC)

Consider hospital supervised treatment

DIAGNOSTIC_TEST

Intensive care management

Manage in hospital as severe pneumonia

Sponsors & Collaborators

  • Fuzhou General Hospital

    lead OTHER

Principal Investigators

  • zongyang yu, Ph.D · The 900th Hospital of the Joint Logistic Support Force, PLA

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-04
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05677789 on ClinicalTrials.gov